S833 Delay in Insurance Approval of Biologic Therapy Dose Escalation Is Associated With Increased Disease Activity in Patients With Inflammatory Bowel Disease. (October 2021) - Shah, Nisha; DeClercq, Josh; Cherry, Laura; Zuckerman, Autumn; Vimalathas, Praveen; Choi, Leena; Donoho, Charles A.; Pabla, Baldeep; Scoville, Elizabeth; Dalal, Robin; Beaulieu, Dawn; Schwartz, David; et al.